Chintan V. Shah

2.5k total citations
17 papers, 54 citations indexed

About

Chintan V. Shah is a scholar working on Pulmonary and Respiratory Medicine, Nutrition and Dietetics and Nephrology. According to data from OpenAlex, Chintan V. Shah has authored 17 papers receiving a total of 54 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Nutrition and Dietetics and 4 papers in Nephrology. Recurrent topics in Chintan V. Shah's work include Magnesium in Health and Disease (5 papers), Potassium and Related Disorders (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chintan V. Shah is often cited by papers focused on Magnesium in Health and Disease (5 papers), Potassium and Related Disorders (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chintan V. Shah collaborates with scholars based in United States and Taiwan. Chintan V. Shah's co-authors include Matthew A. Sparks, Arash Rashidi, Chien‐Te Lee, Bhavna Bhasin, Miroslav Sekulic, William L. Clapp, Sheron Latcha, I. David Weiner, Hyun‐Wook Lee and Xu Zeng and has published in prestigious journals such as Journal of the American Society of Nephrology, American Journal of Kidney Diseases and Seminars in Nephrology.

In The Last Decade

Chintan V. Shah

8 papers receiving 54 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chintan V. Shah United States 5 32 21 17 9 9 17 54
Shuxia Fu China 3 9 0.3× 24 1.1× 7 0.4× 3 0.3× 5 0.6× 7 61
Gesche Düker Germany 3 21 0.7× 56 2.7× 19 1.1× 16 1.8× 3 0.3× 4 70
Roza Blagieva Germany 2 5 0.2× 22 1.0× 18 1.1× 14 1.6× 5 0.6× 3 58
Tomasz Urasiński Poland 5 7 0.2× 24 1.1× 35 2.1× 5 0.6× 8 0.9× 8 78
Aaltje Y Adema Netherlands 6 14 0.4× 85 4.0× 14 0.8× 10 1.1× 8 0.9× 9 111
Е. В. Колмакова Russia 3 10 0.3× 15 0.7× 10 0.6× 13 1.4× 20 2.2× 4 77
Nazareno Carullo Italy 6 8 0.3× 16 0.8× 6 0.4× 9 1.0× 9 1.0× 13 71
Shreyak Sharma United States 3 9 0.3× 21 1.0× 18 1.1× 13 1.4× 6 53
Nathalie Rock Switzerland 5 19 0.6× 3 0.1× 11 0.6× 40 4.4× 7 0.8× 19 104
Xin Mai China 2 9 0.3× 18 0.9× 50 2.9× 7 0.8× 3 0.3× 2 86

Countries citing papers authored by Chintan V. Shah

Since Specialization
Citations

This map shows the geographic impact of Chintan V. Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chintan V. Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chintan V. Shah more than expected).

Fields of papers citing papers by Chintan V. Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chintan V. Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chintan V. Shah. The network helps show where Chintan V. Shah may publish in the future.

Co-authorship network of co-authors of Chintan V. Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Chintan V. Shah. A scholar is included among the top collaborators of Chintan V. Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chintan V. Shah. Chintan V. Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shah, Chintan V.. (2025). Acute Cisplatin Nephrotoxicity, Sodium-Glucose Cotransporter 2 Inhibitors, and Benefits Beyond Magnesium. Journal of the American Society of Nephrology. 36(9). 1883–1884.
2.
Shah, Chintan V., Xu Zeng, & William L. Clapp. (2025). Proliferative Glomerulonephritis With Monoclonal Ig Deposits Without Detectable Clones: Navigating Empirical Clone-Directed Therapy. Kidney International Reports. 10(7). 2480–2483.
3.
Shah, Chintan V., Matthew A. Sparks, & Chien‐Te Lee. (2024). Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review. American Journal of Kidney Diseases. 83(5). 648–658. 12 indexed citations
4.
Shah, Chintan V.. (2024). Sotagliflozin in Refractory Hypomagnesemia. Kidney International Reports. 10(3). 966–967. 1 indexed citations
5.
Shah, Chintan V., et al.. (2024). Pregnancy-Associated Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition. Journal of the American Society of Nephrology. 35(10S).
6.
Shah, Chintan V.. (2024). Role of Glucagon in the Effects of SGLT2 Inhibition on Potassium and Magnesium Homeostasis. Kidney Medicine. 6(9). 100888–100888.
7.
Shah, Chintan V. & I. David Weiner. (2023). Rechallenge in Immune Checkpoint Inhibitors Associated Renal Tubular Acidosis. Kidney International Reports. 8(7). 1476–1477.
8.
Shah, Chintan V., et al.. (2023). SGLT2 Inhibitors in Management of Severe Hypomagnesemia in Patients Without Diabetes: A Report of 4 Cases. Kidney Medicine. 5(9). 100697–100697. 13 indexed citations
9.
Shah, Chintan V., et al.. (2023). Role of Leukapheresis in the Management of AKI Associated with Hyperleukocytosis of Acute Myeloid Leukemia (AML). Journal of the American Society of Nephrology. 34(11S). 472–472.
10.
Shah, Chintan V., et al.. (2023). A brief review of renal-limited thrombotic microangiopathy associated with immune checkpoint inhibitors. 7(2). 105–110. 2 indexed citations
11.
Latcha, Sheron & Chintan V. Shah. (2022). Rescue Therapies for AKI in Onconephrology: Rasburicase and Glucarpidase. Seminars in Nephrology. 42(6). 151342–151342. 1 indexed citations
12.
Shah, Chintan V., et al.. (2022). Sodium-Glucose Cotransporter 2 Inhibitors and Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases. Kidney Medicine. 4(10). 100533–100533. 13 indexed citations
13.
Shah, Chintan V., Hyun‐Wook Lee, William L. Clapp, & I. David Weiner. (2022). A Novel Form of Renal Tubular Acidosis Associated With Immune Checkpoint Inhibitors. Kidney International Reports. 8(1). 197–201. 4 indexed citations
14.
Rashidi, Arash, Chintan V. Shah, & Miroslav Sekulic. (2022). The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI. Kidney360. 3(3). 530–533. 8 indexed citations
15.
Weiner, I. David, Hyun‐Wook Lee, William L. Clapp, & Chintan V. Shah. (2022). A Novel Form of Renal Tubular Acidosis (RTA) Associated With Immune Checkpoint Inhibitors: A Case Report and Literature Review. Journal of the American Society of Nephrology. 33(11S). 741–742.
16.
Henderson, David K., Kenar D. Jhaveri, Rimda Wanchoo, & Chintan V. Shah. (2021). Immune Checkpoint Inhibitors Associated Distal RTA with and Without AKI. Journal of the American Society of Nephrology. 32(10S). 576–576.
17.
Shah, Chintan V., et al.. (2021). Immune Checkpoint Inhibitor (ICPI)-Associated Hypopituitarism Presenting as Severe Hyponatremia. Journal of the American Society of Nephrology. 32(10S). 832–832.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuxia Fu Breakdown of academic impact, for papers by Gesche Düker Breakdown of academic impact, for papers by Roza Blagieva Breakdown of academic impact, for papers by Tomasz Urasiński Breakdown of academic impact, for papers by Aaltje Y Adema Breakdown of academic impact, for papers by Е. В. Колмакова Breakdown of academic impact, for papers by Nazareno Carullo Breakdown of academic impact, for papers by Shreyak Sharma Breakdown of academic impact, for papers by Nathalie Rock Breakdown of academic impact, for papers by Xin Mai
Rankless by CCL
2026